LABD vs. CNCR ETF Comparison
Comparison of Direxion Daily S&P Biotech Bear 3X Shares (LABD) to Loncar Cancer Immunotherapy ETF (CNCR)
LABD
Direxion Daily S&P Biotech Bear 3X Shares
LABD Description
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.
Grade (RS Rating)
Last Trade
$5.76
Average Daily Volume
15,699,334
79
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.Grade (RS Rating)
Last Trade
$14.74
Average Daily Volume
3,771
67
Performance
| Period | LABD | CNCR |
|---|---|---|
| 30 Days | -3.36% | 0.07% |
| 60 Days | 6.17% | -2.25% |
| 90 Days | -9.66% | 3.58% |
| 12 Months | -75.44% | 45.65% |
11 Overlapping Holdings
| Symbol | Grade | Weight in LABD | Weight in CNCR | Overlap | |
|---|---|---|---|---|---|
| ALLO | D | 0.54% | 1.35% | 0.54% | |
| BPMC | C | 1.61% | 1.32% | 1.32% | |
| EXEL | A | 1.91% | 1.39% | 1.39% | |
| FATE | F | 0.67% | 1.03% | 0.67% | |
| IOVA | B | 1.07% | 1.35% | 1.07% | |
| KPTI | C | 0.79% | 1.5% | 0.79% | |
| MGNX | C | 0.25% | 1.55% | 0.25% | |
| PGEN | F | 0.29% | 1.27% | 0.29% | |
| REGN | F | 1.77% | 1.1% | 1.1% | |
| XNCR | A | 0.49% | 1.35% | 0.49% | |
| YMAB | A | 0.24% | 1.54% | 0.24% |
LABD Overweight 68 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| BMRN | F | 1.89% | |
| BLUE | F | 1.87% | |
| VRTX | D | 1.84% | |
| SAGE | F | 1.8% | |
| UTHR | A | 1.78% | |
| AMGN | C | 1.75% | |
| ALNY | C | 1.73% | |
| EXAS | A | 1.73% | |
| ABBV | A | 1.72% | |
| ACAD | F | 1.68% | |
| SRPT | D | 1.66% | |
| BIIB | F | 1.65% | |
| IONS | F | 1.64% | |
| GILD | A | 1.64% | |
| NBIX | C | 1.62% | |
| INCY | A | 1.51% | |
| RARE | D | 1.49% | |
| MRNA | F | 1.47% | |
| LGND | A | 1.46% | |
| ARWR | F | 1.45% | |
| BHVN | B | 1.42% | |
| PTCT | B | 1.4% | |
| FOLD | B | 1.38% | |
| AGIO | B | 1.37% | |
| APLS | F | 1.24% | |
| ALKS | F | 1.21% | |
| MYGN | F | 1.08% | |
| NTRA | B | 1.08% | |
| FGEN | F | 1.05% | |
| RGNX | F | 1.05% | |
| CHRS | F | 0.99% | |
| EBS | B | 0.96% | |
| CDNA | D | 0.93% | |
| HRTX | F | 0.84% | |
| INSM | D | 0.81% | |
| ESPR | C | 0.79% | |
| ALLK | B | 0.76% | |
| IRWD | F | 0.75% | |
| VCYT | A | 0.72% | |
| HALO | B | 0.71% | |
| EDIT | F | 0.66% | |
| PBYI | C | 0.65% | |
| MDGL | A | 0.59% | |
| TGTX | A | 0.55% | |
| ADVM | D | 0.55% | |
| CPRX | A | 0.53% | |
| ANAB | F | 0.53% | |
| SGMO | A | 0.48% | |
| ENTA | D | 0.47% | |
| EGRX | F | 0.42% | |
| GTHX | A | 0.42% | |
| ATRA | C | 0.41% | |
| VKTX | A | 0.38% | |
| ANIK | F | 0.37% | |
| VNDA | D | 0.35% | |
| OPK | C | 0.35% | |
| VCEL | D | 0.34% | |
| TVTX | B | 0.33% | |
| KOD | B | 0.29% | |
| BBIO | D | 0.29% | |
| NTLA | F | 0.29% | |
| DNLI | C | 0.28% | |
| KRYS | C | 0.28% | |
| GOSS | F | 0.27% | |
| VYGR | C | 0.26% | |
| ALEC | D | 0.25% | |
| CYTK | F | 0.25% | |
| DVAX | A | 0.24% |
LABD Underweight 56 Positions Relative to CNCR
| Symbol | Grade | Weight | |
|---|---|---|---|
| BMEA | D | -1.91% | |
| TYRA | F | -1.89% | |
| ELVN | B | -1.75% | |
| HCM | C | -1.74% | |
| ACLX | B | -1.55% | |
| REPL | B | -1.55% | |
| AURA | B | -1.54% | |
| AUTL | D | -1.51% | |
| RVMD | A | -1.47% | |
| BMY | A | -1.43% | |
| DAWN | A | -1.42% | |
| TSVT | D | -1.42% | |
| ARVN | C | -1.42% | |
| MRUS | C | -1.41% | |
| MRSN | D | -1.41% | |
| JANX | A | -1.4% | |
| RPTX | C | -1.39% | |
| RCUS | F | -1.38% | |
| IGMS | B | -1.37% | |
| BCYC | D | -1.37% | |
| SNDX | F | -1.37% | |
| KYMR | C | -1.36% | |
| GNLX | C | -1.32% | |
| ACRV | B | -1.32% | |
| IMCR | F | -1.31% | |
| NRIX | B | -1.31% | |
| ACET | F | -1.3% | |
| CRBU | D | -1.28% | |
| STRO | D | -1.28% | |
| RXRX | F | -1.28% | |
| GERN | C | -1.26% | |
| LYEL | F | -1.25% | |
| CGEM | F | -1.24% | |
| SDGR | F | -1.23% | |
| RAPT | D | -1.23% | |
| ERAS | C | -1.23% | |
| MRK | F | -1.22% | |
| ZNTL | D | -1.22% | |
| BNTX | B | -1.21% | |
| IPHA | D | -1.18% | |
| GLUE | A | -1.17% | |
| LEGN | F | -1.16% | |
| GMAB | F | -1.15% | |
| NUVL | D | -1.13% | |
| FHTX | C | -1.11% | |
| KURA | F | -1.1% | |
| SWTX | D | -1.09% | |
| IDYA | F | -1.08% | |
| RLAY | F | -1.05% | |
| IMRX | D | -1.02% | |
| NUVB | F | -1.02% | |
| ITOS | F | -0.99% | |
| IMTX | F | -0.99% | |
| VOR | D | -0.94% | |
| SMMT | C | -0.92% | |
| PRLD | F | -0.85% |
LABD: Top Represented Industries & Keywords
CNCR: Top Represented Industries & Keywords
Compare ETFs
